about
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis CVariants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypesDysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis CPredictors of consent to pharmacogenomics testing in the IDEAL study.Noninvasive tools to assess liver disease.Host genomics and HCV treatment response.Projections of primary liver cancer to 2030 in 30 countries worldwide.Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia.Use of telehealth to treat and manage chronic viral hepatitis in regional Queensland.Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability.Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy.Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.Lost in translation? IL28B's discovery and the journey back to the patient.Overcoming barriers to care for hepatitis C.Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.Enhancing hepatitis C treatment in the custodial setting: a national roadmap.Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size.Bilirubin acts as a multi-potent guardian of cardiovascular integrity: more than just a radical idea.Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading.Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancerUsing Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient PopulationsMore needs to be spent on hepatitis C treatment, not lessUtility of eosinophilia as a diagnostic clue in lower abdominal pain in northern Australia: a retrospective case-control studyResolution of protein-losing enteropathy after successful heart transplantation in an adult patient with arrhythmogenic right ventricular cardiomyopathy (ARVC)Genetic variation in IL28B: impact on drug development for chronic hepatitis C infectionInsights into the hepatocellular carcinoma patient journey: results of the first global quality of life surveyTrends in hepatitis C treatment uptake in the United States
P50
Q33395929-9C37EEB5-929D-485D-9F44-965519FC18C0Q33746198-1F25AB69-9D57-43F5-8190-D903936B432DQ33755525-A0590EB4-4E0F-416D-BBC6-1FC416319897Q33959382-50CB4D2E-55FA-46F7-9CA3-72EEF674E9C2Q35332315-D9378D80-5137-404B-9893-22A0A6FA6D0FQ35508148-F537D673-DB2B-4971-9839-8030BDC3210DQ35768047-9283F07B-DA10-428B-BEED-A067A7F52738Q35992420-4AAEE5AB-57C9-4FBA-8E39-F6AD338F3045Q36457818-A7309F40-2AD5-485F-9BAF-3A4995E035F6Q36457831-AD1FDC80-C590-4AE6-8B44-82199F8D8DA4Q36967102-F34DEAD3-05F3-45E4-A030-9581A916078DQ37149463-6D409CC0-3F36-42FF-A026-37B3D1956069Q37633696-695B6482-7F58-455A-887F-87DBEC0AAD47Q37830283-18AABF2F-61F0-4CCA-8A5D-E03204C1B69BQ37932036-9C97A87F-2415-405A-9A64-B60825329209Q38634903-8856CD4F-E84A-40AF-9788-FF0CFD8CC0CDQ38987559-0FF2DA3A-EE71-428F-95B4-70E325702050Q39229834-5C377314-BBCA-4F41-87CA-6039647EEE31Q39758401-3536B8E7-7793-4A93-8601-4C3C6664F971Q40155391-A27DB338-4B23-4871-982F-79E7C84CE414Q40898374-971C607E-C855-4CA7-9CF2-65F85CF7606EQ41031631-F306B236-C4FB-4FBB-89DA-CB2615CAB446Q41407411-5E237EBB-8D3D-42A7-8B31-2FDB3592FF5EQ42979469-1059625B-14BA-4DB2-B655-5614A4C4F404Q42981735-57B2F4C6-4313-4EB0-ABCC-44A579995E8EQ43000356-FC9CF786-F7B0-47CE-9F39-78E3D67F2379Q43623341-6D2851C4-F6E2-4F7F-92E0-9C063CA10783Q47173917-35335B9A-DE4E-40D7-99E3-81000AC6BE3FQ51732276-E4981D55-4091-4774-A0CE-C5D40EF7D041Q52563107-3F670FBF-07DF-4ED3-ADC9-B369D0FB54A4Q57742466-EB1D5235-9F3A-400A-A213-A0C24F975FBEQ59355746-623B6B71-254B-4F50-9E01-A437D9F92F1FQ63440807-429348B6-77E9-41DE-B79A-41A4CED84D1FQ80993139-5FAC4026-D264-4572-A1F8-CA1C74BAB7AEQ81228081-FFF26370-1E99-4123-9FA0-5259391359AFQ85112486-DE349EA3-B49E-45F6-AB89-7B7C1C0E8A2DQ88067344-05D0685F-B304-4C1A-9210-55E923AADB76Q88108771-EB107984-8E9E-460B-A73C-FD65A51930D5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul J Clark
@ast
Paul J Clark
@en
Paul J Clark
@es
Paul J Clark
@nl
type
label
Paul J Clark
@ast
Paul J Clark
@en
Paul J Clark
@es
Paul J Clark
@nl
prefLabel
Paul J Clark
@ast
Paul J Clark
@en
Paul J Clark
@es
Paul J Clark
@nl
P106
P1153
36476979600
P31
P496
0000-0002-1821-4969